Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Data Use Agreement and Supplement for 2014 Health Center Patient Survey, 69834-69835 [2016-24300]
Download as PDF
<![CDATA[
69834
Federal Register / Vol. 81, No. 195 / Friday, October 7, 2016 / Notices
The docket will close 30 days after
those documents are posted.
Transcripts: Please be advised that as
soon as a transcript is available, it will
be accessible at in the docket at https://
www.regulations.gov. It may be viewed
at the Division of Dockets Management
(see ADDRESSES). A transcript will also
be available in either hardcopy or on
CD–ROM, after submission of a
Freedom of Information request. The
Freedom of Information office address is
available on the Agency’s Web site at
https://www.fda.gov. A link to the
transcripts will also be available
approximately 45 days after the public
workshop on the Internet at https://
www.fda.gov/ForIndustry/UserFees/
MedicalDeviceUserFee/ucm454039.htm.
(Select this meeting from the posted
events list).
Dated: October 3, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016–24237 Filed 10–6–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request; Data Use Agreement and
Supplement for 2014 Health Center
Patient Survey
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, HRSA submitted
an Information Collection Request (ICR)
to the Office of Management and Budget
(OMB) for review and approval.
Comments submitted during the first
public review of this ICR will be
provided to OMB. OMB will accept
further comments from the public
during the review and approval period.
SUMMARY:
Comments on this ICR should be
received no later than November 7,
2016.
ADDRESSES: Submit your comments,
including the ICR title, to the desk
officer for HRSA, either by email to
OIRA_submission@omb.eop.gov or by
fax to 202–395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email the
HRSA Information Collection Clearance
Officer at paperwork@hrsa.gov or call
(301) 443–1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Data Use Agreement and Supplement
for 2014 Health Center Patient Survey.
OMB No.: 0906–xxxx—NEW.
Abstract: The Health Center Patient
Survey (HCPS), sponsored by HRSA’s
Bureau of Primary Health Care (BPHC),
surveyed patients who use health
centers funded under Section 330 of the
Public Health Service Act. HCPS
collects data on health center patients’
sociodemographic characteristics,
health conditions, health behaviors,
access to and utilization of health care
services, and satisfaction with health
care. Survey results come from inperson, one-on-one interviews with
patients and are nationally
representative of the Health Center
program patient population. To inform
BPHC and HHS policy, funding, and
planning decisions, the survey
investigated how well HRSA-supported
sites meet health care needs of the
medically underserved and assessed
how patients perceive the quality of
their care.
The HCPS is unique because it
focuses on comprehensive patient-level
data. These and other features of the
data will provide researchers and
policymakers the capacity to
empirically explore policy relevant
topics relevant to the Health Center
program using up-to-date information.
Prior to releasing this information,
BPHC will request prospective users to
fill out a ‘‘Data Use Agreement’’ (DUA).
BPHC uses DUAs as legal binding
agreements when an external entity
(e.g., contractor, private industry,
academic institution, other federal
DATES:
government agency, or state agency)
requests the use of BPHC personally/
organizationally identifiable data that is
covered by the Privacy Act of 1974. The
agreement delineates the confidentiality
requirements of the Privacy Act,
security safeguards, and BPHC’s data
use policies and procedures. The DUA
will serve as both a means of informing
data users of these requirements and a
means of obtaining their agreement to
abide by these requirements.
Need and Proposed Use of the
Information: Before allowing access to
unrestricted data that contains sensitive
grantee and patient information that is
protected by the Privacy Act of 1974,
prospective users will submit a signed
DUA and describe what proposed
research they intend to undertake in
using the dataset. A BPHC workgroup
will determine whether the project is an
appropriate and legitimate use of the
data. The criteria to determine
admissible projects will include: (1)
Relevance of the topic of study to
BPHC/HHS policy; (2) feasibility of the
project given the parameters described
in DUA supplemental; and (3) the
proposed end-use of the research that
will be undertaken.
Likely Respondents: Prospective
researchers in academia, private
contractors, and Primary Care
Associations/Health Center grantee
organizations.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
mstockstill on DSK3G9T082PROD with NOTICES
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
DUA ......................................................................................
DUA Supplemental ..............................................................
20
20
1
1
20
20
0.25
1.25
5
25
Total ..............................................................................
40
........................
40
........................
30
VerDate Sep<11>2014
17:36 Oct 06, 2016
Jkt 241001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\07OCN1.SGM
07OCN1
Federal Register / Vol. 81, No. 195 / Friday, October 7, 2016 / Notices
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016–24300 Filed 10–6–16; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
mstockstill on DSK3G9T082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR13–
309–311: Translational Research in Pediatric
and Obstetric Pharmacology and
Therapeutics.
Date: November 1, 2016.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA AI016–
025: Non-vaccine Biomedical Prevention
(nBP) of HIV Acquisition/Transmission.
Date: November 1, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Jingsheng Tuo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
Bethesda, MD 20892, 301–451–8754, tuoj@
nei.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Biomedical
Research Shared Instrumentation.
Date: November 1, 2016.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:36 Oct 06, 2016
Jkt 241001
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Kathryn Kalasinsky, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158
MSC 7806, Bethesda, MD 20892, 301–402–
1074, kalasinskyks@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Infectious Diseases.
Date: November 1, 2016.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: John C Pugh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7808, Bethesda, MD 20892, (301) 435–
2398, pughjohn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Small Business: Serious STEM Games for
Pre-College and Informational Science
Education Audiences.
Date: November 2, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Allen Richon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, 301–379–
9351, allen.richon@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict Bioengineering Sciences #2.
Date: November 2, 2016.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Joseph Thomas Peterson,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9694, petersonjt@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Shared
Instrumentation: Confocal Microscopy and
Imaging.
Date: November 3–4, 2016.
Time: 8:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Thomas Beres, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Dr. Rm. 5201, MSC
7840, Bethesda, MD 20892, 301–435–1175,
berestm@mail.nih.gov.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
69835
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Shared
Instrumentation: Electron Microscopy.
Date: November 4, 2016.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Thomas Beres, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Dr. Rm. 5201, MSC
7840, Bethesda, MD 20892, 301–435–1175,
berestm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 3, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–24254 Filed 10–6–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the NIH Clinical Center
Research Hospital Board scheduled for
October 21, 2016, 9:00 a.m. to 5:00 p.m.,
in Conference Room 6C6, Building 31,
National Institutes of Health, Bethesda,
MD 20892, which was published in the
Federal Register on September 16, 2016,
81 FR 63778.
A discussion of the reports from the
Anonymous Safety Hotline developed
by NIH for Clinical Center staff,
patients, or visitors to report any
concerns about care or unsafe
conditions has been added to the closed
portion of the meeting. This portion will
be closed to the public in accordance
with the provisions set forth in section
552b(c)(9)(B) and 552b(c)(6), Title 5
U.S.C., as amended. The premature
disclosure of the laboratories or units
and staff involved in the individual
reports could significantly limit the
Hotline’s purpose by compromising
anonymity. These actions would
frustrate NIH’s use of this resource as it
strives to improve the overall safety and
quality of care at the Clinical Center.
There are no changes for the open
portion of the meeting that was
advertised on September 16, 2016.
E:\FR\FM\07OCN1.SGM
07OCN1
]]>Agencies
[Federal Register Volume 81, Number 195 (Friday, October 7, 2016)]
[Notices]
[Pages 69834-69835]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-24300]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission to OMB for
Review and Approval; Public Comment Request; Data Use Agreement and
Supplement for 2014 Health Center Patient Survey
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, HRSA submitted an Information Collection Request
(ICR) to the Office of Management and Budget (OMB) for review and
approval. Comments submitted during the first public review of this ICR
will be provided to OMB. OMB will accept further comments from the
public during the review and approval period.
DATES: Comments on this ICR should be received no later than November
7, 2016.
ADDRESSES: Submit your comments, including the ICR title, to the desk
officer for HRSA, either by email to OIRA_submission@omb.eop.gov or by
fax to 202-395-5806.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email the HRSA Information
Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443-
1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: Data Use Agreement and
Supplement for 2014 Health Center Patient Survey.
OMB No.: 0906-xxxx--NEW.
Abstract: The Health Center Patient Survey (HCPS), sponsored by
HRSA's Bureau of Primary Health Care (BPHC), surveyed patients who use
health centers funded under Section 330 of the Public Health Service
Act. HCPS collects data on health center patients' sociodemographic
characteristics, health conditions, health behaviors, access to and
utilization of health care services, and satisfaction with health care.
Survey results come from in-person, one-on-one interviews with patients
and are nationally representative of the Health Center program patient
population. To inform BPHC and HHS policy, funding, and planning
decisions, the survey investigated how well HRSA-supported sites meet
health care needs of the medically underserved and assessed how
patients perceive the quality of their care.
The HCPS is unique because it focuses on comprehensive patient-
level data. These and other features of the data will provide
researchers and policymakers the capacity to empirically explore policy
relevant topics relevant to the Health Center program using up-to-date
information.
Prior to releasing this information, BPHC will request prospective
users to fill out a ``Data Use Agreement'' (DUA). BPHC uses DUAs as
legal binding agreements when an external entity (e.g., contractor,
private industry, academic institution, other federal government
agency, or state agency) requests the use of BPHC personally/
organizationally identifiable data that is covered by the Privacy Act
of 1974. The agreement delineates the confidentiality requirements of
the Privacy Act, security safeguards, and BPHC's data use policies and
procedures. The DUA will serve as both a means of informing data users
of these requirements and a means of obtaining their agreement to abide
by these requirements.
Need and Proposed Use of the Information: Before allowing access to
unrestricted data that contains sensitive grantee and patient
information that is protected by the Privacy Act of 1974, prospective
users will submit a signed DUA and describe what proposed research they
intend to undertake in using the dataset. A BPHC workgroup will
determine whether the project is an appropriate and legitimate use of
the data. The criteria to determine admissible projects will include:
(1) Relevance of the topic of study to BPHC/HHS policy; (2) feasibility
of the project given the parameters described in DUA supplemental; and
(3) the proposed end-use of the research that will be undertaken.
Likely Respondents: Prospective researchers in academia, private
contractors, and Primary Care Associations/Health Center grantee
organizations.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
Total Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of Total burden per Total burden
Form name respondents responses per responses response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
DUA............................. 20 1 20 0.25 5
DUA Supplemental................ 20 1 20 1.25 25
-------------------------------------------------------------------------------
Total....................... 40 .............. 40 .............. 30
----------------------------------------------------------------------------------------------------------------
[[Page 69835]]
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016-24300 Filed 10-6-16; 8:45 am]
BILLING CODE 4165-15-P
